Investors & Media

Overview

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps, cramps and spasms associated with severe neuromuscular conditions such as MS and ALS, and exercise-associated muscle cramps. Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D.

Stock Quote
FLKS (Common Stock)
Price & Exchange$6.21 (US Dollar)
NASDAQ GS
Change (%) Stock is Down 0.09 (1.43%)
Volume47,709
Data as of 12/07/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Upcoming EventsMore >>
There are currently no events scheduled.
Data Provided by Thomson Reuters